We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1208:HKEXMMG Limited Analysis

Data as of 2026-05-24 - not real-time

HK$9.14

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MMG Limited is trading at HK$9.14, just below its 20‑day SMA of 9.20 but comfortably above the 50‑day (8.60) and 200‑day (7.72) averages, indicating a lingering bullish bias despite a recent pull‑back. The RSI sits at 50.5, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, flagging short‑term downside pressure. Fundamentally, the company posted a 32.8% revenue surge and maintains healthy gross (56%) and operating (36%) margins, supported by robust operating cash flow of HK$2.69 bn. However, the DCF‑derived fair value of HK$3.87 is far below the current price, implying the stock is overvalued on intrinsic terms, even as the forward PE of 9.2 signals strong earnings upside. The market sentiment is extremely bullish (Fear‑Greed Index 91.6), which together with a 56% 30‑day volatility and a beta near 1.05 underscores heightened price swings. No dividend is paid, so income‑focused investors have no yield cushion. Geographic exposure spans Peru, Australia, Botswana and the DRC, adding layers of regulatory and political risk. Overall, the stock balances solid growth fundamentals against a lofty valuation and considerable short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and proximity to short‑term resistance
  • Current price above DCF fair value
  • Elevated 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and expanding operating margins
  • Forward PE compression indicating earnings acceleration
  • Fundamental cash‑flow generation supporting upside potential

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to long‑term copper demand trends
  • Sustained cash‑flow and low debt service risk
  • Persistently high valuation relative to intrinsic estimates

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin8.19%
P/E Ratio27.7
ROE14.50%
ROA9.22%
Debt/Equity55.34
P/B Ratio3.6
Op. Cash FlowHK$2.7B
Free Cash FlowHK$1.4B

Technical Analysis

TrendBullish
RSI50.5
SupportHK$7.96
ResistanceHK$10.82
MA 20HK$9.20
MA 50HK$8.60
MA 200HK$7.72
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair ValueHK$3.87
Target PriceHK$11.57
Upside/Downside26.56%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.05
Volatility56.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.